In the first half of the current fiscal year, imports of surgical products and equipment reached $621.59 million, an increase from the $557.68 million recorded in the same period last fiscal year. Imports increased by 13.03 percent in terms of...
The increase in chronic illnesses is anticipated to drive the need for specialty generic products. There is expected to be a significant increase in the size of the specialty generics market in the coming years. The amount is projected to reach...
India's medical technology sector is projected to reach exports worth USD 20 billion by 2030. The industry body CII mentioned that in order to boost international shipments, the sector requires more government incentives and improved ease of doing...
The pharmaceutical sector is projected to reach $70.3 billion, with a 9 percent growth expected from FY25 to FY27, fueled by rising exports to nations such as the US, as well as by new products introduced by Indian pharmaceutical firms. It is...
In the upcoming five years, almost 70 percent of international pharmaceutical companies are predicted to experience yearly growth of over 10 percent in India. International pharmaceutical corporations have been essential in the change by bringing...
India's pharmaceutical industry, known for being a major player in global healthcare, is projected to reach an impressive value of USD 450 billion by 2047. India continues to be a major player in the international pharmaceutical market, with...
Many pharmaceutical companies prioritize digital transformation to enhance their ability to collect, analyze, and store data for future use, driving the increasing demand for the pharma 4.0 market. Utilizing industry 4.0 technology in the...
India exports a large amount of Pharmaceuticals to more than 200 countries around the world. The current worth of the pharmaceutical sector in India is $50 billion. India meets more than half of Africa's generic drug needs, 40% of generic drug...
The pharmaceutical analytical testing market is experiencing substantial expansion due to increased complexity in drug development and growing need for biologics and biosimilars, as per the report by Straits Research Pvt. Ltd...
Lupin has one of the quickest increases in the S&P Global ESG scores among pharmaceutical companies in India. Lupin Limited, a leading pharmaceutical company, reported an increase in its S&P Global ESG scores from 69 to 76, surpassing the industry...
, CDSCO.jpg)
